Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$142.57 - $190.86 $57,028 - $76,344
-400 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $42,735 - $50,946
-300 Reduced 42.86%
400 $67,000
Q1 2021

May 17, 2021

SELL
$137.51 - $190.8 $68,755 - $95,400
-500 Reduced 41.67%
700 $97,000
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $197,556 - $254,316
1,200 New
1,200 $210,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.